CD19 CAR T cell product and disease attributes predict leukemia remission durability

Journal of Clinical Investigation - Tập 129 Số 5 - Trang 2123-2132 - 2019
Olivia Finney1, Hannah Brakke1, Stephanie D. Rawlings‐Rhea1, Roxana Hicks1, Danielle Doolittle1, Marisa Lopez1, Ben Futrell1, Rimas J. Orentas1, Daniel Li2, Rebecca Gardner1,3,4, Michael C. Jensen1,5,4
1Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA
2Clinical Statistics Group, Juno Therapeutics, Inc., Seattle, Washington, USA.
3Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington, USA.
4Department of Pediatrics, University of Washington, Seattle, Washington USA
5Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1200/JCO.2016.67.3301

10.1002/cncr.28136

10.1002/cpt.950

Huang, 2015, Cellular and antibody based approaches for pediatric cancer immunotherapy, J Immunol Res, 2015, 10.1155/2015/675269

10.1080/17460441.2016.1237939

10.1016/S0140-6736(14)61403-3

10.1056/NEJMoa1407222

10.1172/JCI85309

Gardner, 2017, Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults, Blood, 129, 3322, 10.1182/blood-2017-02-769208

10.1182/blood-2016-02-629063

10.1007/s11864-016-0406-4

10.1126/scitranslmed.aad5222

10.1182/blood-2011-02-337360

10.1038/leu.2015.247

10.1172/JCI32103

10.1182/blood-2014-01-552174

Klaver, 2016, T cell maturation stage prior to and during GMP processing informs on CAR T cell expansion in patients, Front Immunol, 7, 10.3389/fimmu.2016.00648

10.1126/scitranslmed.aac8265

10.1158/2326-6066.CIR-14-0127

10.1056/NEJMoa1707447

10.1056/NEJMoa1709866

10.1146/annurev.immunol.23.021704.115658

10.1038/s41591-018-0010-1

Rossi, 2018, Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL, Blood, 132, 804, 10.1182/blood-2018-01-828343

10.1126/science.aae0491

10.1016/j.immuni.2007.09.006

10.1038/nri3862

10.1007/BF01789334

Mackall, 1994, Lymphocyte depletion during treatment with intensive chemotherapy for cancer, Blood, 84, 2221, 10.1182/blood.V84.7.2221.2221

Mackall, 1997, Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy, Blood, 89, 3700, 10.1182/blood.V89.10.3700

10.1182/blood-2005-03-1082

Ogonek, 2016, Immune reconstitution after allogeneic hematopoietic stem cell transplantation, Front Immunol, 7, 10.3389/fimmu.2016.00507

10.1182/blood-2010-10-310599

10.1158/2326-6066.CIR-14-0163

10.1182/blood-2004-03-1208

Fry, 2017, CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19- targeted CAR immunotherapy, Nat Med, 24, 20, 10.1038/nm.4441

Thông tin
Thông tin xuất bản

Journal of Clinical Investigation

Tập 129 Số 5

2123-2132

Thông tin tác giả